Elevation of ganglioside degradation pathway drives GM2 and GM3 within amyloid plaques in a transgenic mouse model of Alzheimer's disease
Alzheimer's disease (AD) is a progressive neurodegenerative disease that accounts for two-thirds of all dementia cases, and age is the strongest risk factor. In addition to the amyloid hypothesis, lipid dysregulation is now recognized as a core component of AD pathology. Gangliosides are a clas...
Saved in:
| Main Authors: | Wenxuan Wang, Sarah J. Myers, Nikita Ollen-Bittle, Shawn N. Whitehead |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Series: | Neurobiology of Disease |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996125000142 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Disease‐modifying effects of ganglioside GM1 in Huntington's disease models
by: Melanie Alpaugh, et al.
Published: (2017-10-01) -
The presence of Mycoplasma pneumoniae infection and GM1 ganglioside antibodies in Guillain-Barré syndrome
by: Mridula B Sharma, et al.
Published: (2011-03-01) -
Gangliosides in milk
by: Slavica Potočki, et al.
Published: (2016-07-01) -
C18:0 GM3 ganglioside’s efficacy in LPS-induced parkinsonism: neuroprotection, inflammatory inhibition and gliosis mitigation
by: Tsung-Ta Liu, et al.
Published: (2025-07-01) -
An Optimized Liquid Chromatography–Mass Spectrometry Method for Ganglioside Analysis in Cell Lines
by: Akeem Sanni, et al.
Published: (2024-10-01)